Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection Group.

Graham BS, McElrath MJ, Connor RI, Schwartz DH, Gorse GJ, Keefer MC, Mulligan MJ, Matthews TJ, Wolinsky SM, Montefiori DC, Vermund SH, Lambert JS, Corey L, Belshe RB, Dolin R, Wright PF, Korber BT, Wolff MC, Fast PE
J Infect Dis. 1998 177 (2): 310-9

PMID: 9466516 · DOI:10.1086/514209

MeSH Terms (21)

Adult AIDS Vaccines Amino Acid Sequence CD4 Lymphocyte Count Female HIV-1 HIV Antibodies HIV Envelope Protein gp120 HIV Infections Humans Immunity, Active Incidence Male Middle Aged Molecular Sequence Data Neutralization Tests Peptide Fragments Risk-Taking Sequence Analysis Substance Abuse, Intravenous Viral Load

Connections (1)

This publication is referenced by other Labnodes entities: